News
Liquidating its stake in Arrowhead helps Sarepta cover a milestone payment and secure what one analyst described as ...
44m
Stocktwits on MSNThis Analyst Says Sarepta Lost Credibility By Exiting Arrowhead At A Loss, But Retail Sees Stock Hitting $30 By Next Week
H.C. Wainwright stated on Thursday that Sarepta Therapeutics’ (SRPT) recent divestiture in Arrowhead (ARWR) weakened its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results